Overall rank by patents
#9,312
of 50,000 tracked assignees
USPTO PatentsView assignee record - 34 granted patents across 15 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
The verdict
According to USPTO PatentsView, Magarl ranks #9,312 of 50,000 tracked US assignees by granted-patent volume, with 34 patents across 15 technology areas.
Magarl, Llc has been granted 34 US utility patents between 2015 and 2024, placing Magarl, Llc at #9,312 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.0 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, Magarl, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Magarl sits between Mobiletron Electronics Co., Ltd. (34 patents, rank #9,316) and Medtronic Ventor Technologies Ltd. (34 patents, rank #9,324) - the closest US assignees by grant volume. The composite Innovation Score of 39.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 13 grants, compared with 21 in the 2015–2019 window, a -38% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Magarl, Llc's 15.0 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 15 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MOBILETRON ELECTRONICS CO., LTD.
34 patents
MOLD-MASTERS (2007) LIMITED
34 patents
MOVING MAGNET TECHNOLOGIES
34 patents
MZ IP Holdings, LLC
34 patents
Mahindra and Mahindra Limited
34 patents
Mainetti (UK) Ltd
34 patents
Maquet Cardiopulmonary GmbH
34 patents
Medtronic Ventor Technologies Ltd.
34 patents
Magarl, LLC
34 patents
What this shows Magarl holds 34 patents at rank #9,320, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #9,320 in granted patent volume.
Other assignees with the most granted patents in Magarl's primary technology class.
Two PlainPatent-derived peer sets for Magarl, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (39 here).
Magarl's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 8.8% |
| 2016 | 4 | 11.8% |
| 2017 | 4 | 11.8% |
| 2018 | 3 | 8.8% |
| 2019 | 7 | 20.6% |
| 2020 | 1 | 2.9% |
| 2021 | 4 | 11.8% |
| 2022 | 3 | 8.8% |
| 2023 | 4 | 11.8% |
| 2024 | 1 | 2.9% |
Top 15 of 15 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#9,312
of 50,000 tracked assignees
39.4 out of 100
How to use this portfolio
Magarl's 34 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.